Influenza, B cells, Antibodies, Vaccination
Showing 1 - 25 of >10,000
Influenza Trial (Existing Influenza Vaccination Practices, Standardized inpatient influenza vaccination program)
Not yet recruiting
- Influenza
- Existing Influenza Vaccination Practices
- Standardized inpatient influenza vaccination program
- (no location specified)
Apr 24, 2023
Immune Response Trial in Maastricht (Influenza vaccine, Agaricus bisporus capsules, Control capsules)
Not yet recruiting
- Immune Response
- Influenza vaccine
- +2 more
-
Maastricht, Limburg, NetherlandsMaastricht University Medical Center
Sep 11, 2023
Influenza, Human Trial in Birmingham (Treatment Group Live Attenuated Flu Vaccine (LAIV))
Completed
- Influenza, Human
- Treatment Group Live Attenuated Flu Vaccine (LAIV)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 16, 2022
Antibodies in Repeated Influenza Vaccination (ARIVA) Study
Completed
- Vaccine Response Impaired
- Influenza Vaccination
-
Basel, SwitzerlandUniversity Hospital Basel
Sep 27, 2021
Guidelines VAccination in Type 1 DIabetes Mellitus Patients
Not yet recruiting
- Type 1 Diabetes
- Covid-19 vaccination
- +3 more
- (no location specified)
Jul 28, 2022
HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)
Not yet recruiting
- HIV-1-infection
- VRC07-523LS
- +7 more
-
Pathum Wan, Bangkok, Thailand
- +1 more
Mar 8, 2023
Plasma Cell Tumor Trial in Atlanta (Pneumococcal 13-valent Conjugate Vaccine, Trivalent Influenza Vaccine)
Active, not recruiting
- Plasma Cell Neoplasm
- Pneumococcal 13-valent Conjugate Vaccine
- Trivalent Influenza Vaccine
-
Atlanta, Georgia
- +1 more
Jan 24, 2022
Hepatitis B Trial in Bangkok, Khon Kaen (Euvax B®: Hepatitis B vaccine)
Completed
- Hepatitis B
- Euvax B®: Hepatitis B vaccine
-
Bangkok, Thailand
- +1 more
Mar 28, 2022
IBD, Ulcerative Colitis, Crohn Disease Trial in Stanford (Vitamin D)
Recruiting
- Inflammatory Bowel Diseases
- +2 more
- Vitamin D
-
Stanford, CaliforniaStanford University School of Medicine
Oct 24, 2022
Moderate to Severe Asthma Trial in United States (Tezepelumab, Placebo)
Completed
- Moderate to Severe Asthma
- Tezepelumab
- Placebo
-
Bakersfield, California
- +14 more
Sep 28, 2022
Fever After Vaccination, Fever, Seizures Fever Trial in United States (Pfizer-BioNTech COVID-19 Vaccine, Routine Childhood
Not yet recruiting
- Fever After Vaccination
- +2 more
- Pfizer-BioNTech COVID-19 Vaccine
- Routine Childhood Vaccinations
-
Oakland, California
- +4 more
Sep 8, 2023
Herpes Virus Infections in Kidney Transplant Patients
Recruiting
- Kidney Transplant; Complications
- +2 more
-
Aarhus, Denmark
- +4 more
Jan 30, 2023
COVID-19 Trial in Vienna (Ad26COVS1, ChAdOx1 SARS2 Vaccine, BNT162B2)
Active, not recruiting
- COVID-19
- Ad26COVS1
- +3 more
-
Vienna, AustriaMedicial University of Vienna
Apr 12, 2022
Donor Specific B Cells and Antibody Mediated Rejection
Terminated
- Sensitized Kidney Transplant Recipients
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Dec 13, 2021
Hepatitis B Trial in New York (Hepatitis B Vaccine (Recombinant))
Not yet recruiting
- Hepatitis B
- Hepatitis B Vaccine (Recombinant)
-
New York, New YorkThe Rockefeller University
Jun 28, 2022
Influenza, Influenza Immunisation Trial in Atlanta (Influenza Virus Vaccine Inactivated)
Completed
- Influenza
- Influenza Immunisation
- Influenza Virus Vaccine Inactivated
-
Atlanta, GeorgiaEmory Clinic - Winship Cancer Institute
Aug 5, 2021
ARDS, Human, Covid19 Trial in Miami, Baltimore, Winston-Salem (Longeveron Mesenchymal Stem Cells (LMSCs), Placebo)
Recruiting
- ARDS, Human
- Covid19
- Longeveron Mesenchymal Stem Cells (LMSCs)
- Placebo
-
Miami, Florida
- +2 more
Nov 3, 2022
Influenza, Human Trial in Philadelphia (Seasonal influenza vaccine)
Recruiting
- Influenza, Human
- Seasonal influenza vaccine
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Nov 17, 2022
Vaccination; Infection Trial (Vaccine injection)
Not yet recruiting
- Vaccination; Infection
- Vaccine injection
- (no location specified)
Oct 12, 2023
Large B-cell Lymphoma Trial in Philadelphia (mosunetuzumab, glofitamab, obinutuzumab)
Recruiting
- Large B-cell Lymphoma
- mosunetuzumab
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jul 21, 2022
COVID 19 Vaccine Trial in Hong Kong (BNT162b2)
Active, not recruiting
- COVID 19 Vaccine
- BNT162b2
-
Hong Kong, Hong KongThe University of Hong Kong
Dec 23, 2021
Does Repeat Influenza Vaccination Constrain Influenza Immune
Recruiting
- Influenza, Human
- SARS-CoV-2 Infection
- Influenza vaccination: Fluarix Tetra, Vaxigrip Tetra, Fluquadri, Fluad Quad, Afluia Quad, Flucelvax Quad
- SARS-CoV-2 vaccination: Comirnaty or Vaxzevria
-
New Lambton Heights, New South Wales, Australia
- +5 more
Nov 7, 2022
Influenza A, Pandemic Influenza Trial in Oslo (H7HLAII)
Recruiting
- Influenza A
- Pandemic Influenza
- H7HLAII
-
Oslo, NorwayOslo University Hospital
Sep 20, 2023
COVID-19 : Neutralizing Human Monoclonal Antibodies Against
Completed
- COVID
- Blood sample
-
Lyon, FranceHôpital de la Croix-Rousse
Jun 17, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (biological, drug, other)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
- +6 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 24, 2022